Grim, C. C. A.
van der Wal, L. I.
Helmerhorst, H. J. F.
van Westerloo, D. J.
Pelosi, P.
Schultz, M. J.
de Jonge, E.
,
del Prado, M. R.
Wigbers, J.
Sigtermans, M. J.
Dawson, L.
van der Heijden, P. L. J.
den Berg, E. Y. Schriel-van
Loef, B. G.
Reidinga, A. C.
de Vreede, E.
Qualm, J.
Boerma, E. C.
Rijnhart-de Jong, H.
Koopmans, M.
Cornet, A. D.
Krol, T.
Rinket, M.
Vermeijden, J. W.
Beishuizen, A.
Schoonderbeek, F. J.
van Holten, J.
Tsonas, A. M.
Botta, M.
Winters, T.
Horn, J.
Paulus, F.
Loconte, M.
Battaglini, D.
Ball, L.
Brunetti, I.
Funding for this research was provided by:
nederlandse organisatie voor wetenschappelijk onderzoek (401.16.009)
Article History
Received: 30 July 2021
Accepted: 29 January 2022
First Online: 13 February 2022
Declarations
:
: The trial protocol is written and will be conducted in accordance to the Declaration of Helsinki (2013). The ethical approval has been granted by local medical ethics committee of Leiden, Den Haag, and Delft in the Netherlands (committee reference number P18.109). In Italy, local approval will be obtained. Informed consent will be obtained from all participants, using a deferred consent principle as described in paragraph 26a.
: Not applicable, since no personally identifiable information is used.
: The authors declare that they have no competing interests.